Evidence map›Paper›PMID 39819740›Full record

ArticleIUCrJ2025

A new statistical metric for robust target detection in cryo-EM using 2D template matching.

Kexin Zhang, Pilar Cossio, Aaditya V Rangan, Bronwyn A Lucas, Nikolaus Grigorieff

Abstract read
In one paragraph

Article in IUCrJ, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kexin ZhangRNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, USA.
Pilar CossioCenter for Computational Mathematics, Flatiron Institute, New York, USA.
Aaditya V RanganCenter for Computational Mathematics, Flatiron Institute, New York, USA.
Bronwyn A LucasRNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, USA.
Nikolaus GrigorieffRNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, USA.ORCID 0000-0002-1506-909X

Funding

Chan Zuckerberg Initiative 2021-234617 (5022)
6 · The paper itself

Abstract

2D template matching (2DTM) can be used to detect molecules and their assemblies in cellular cryo-EM images with high positional and orientational accuracy. While 2DTM successfully detects spherical targets such as large ribosomal subunits, challenges remain in detecting smaller and more aspherical targets in various environments. In this work, a novel 2DTM metric, referred to as the 2DTM p-value, is developed to extend the 2DTM framework to more complex applications. The 2DTM p-value combines information from two previously used 2DTM metrics, namely the 2DTM signal-to-noise ratio (SNR) and z-score, which are derived from the cross-correlation coefficient between the target and the template. The 2DTM p-value demonstrates robust detection accuracies under various imaging and sample conditions and outperforms the 2DTM SNR and z-score alone. Specifically, the 2DTM p-value improves the detection of aspherical targets such as a modified artificial tubulin patch particle (500 kDa) and a much smaller clathrin monomer (193 kDa) in simulated data. It also accurately recovers mature 60S ribosomes in yeast lamellae samples, even under conditions of increased Gaussian noise. The new metric will enable the detection of a wider variety of targets in both purified and cellular samples through 2DTM.

Indexed as

Cryoelectron MicroscopyImage Processing, Computer-AssistedAlgorithmsSignal-To-Noise RatioTubulinTubulin3D reconstruction and image processingcryo-electron microscopyimagingprotein structuresingle-particle cryo-EMstructure determination

Identifiers

PMID39819740
PMCPMC11878444

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.